Literature DB >> 23336044

A dialogue between the immune system and brain, spoken in the language of serotonin.

Nicole L Baganz1, Randy D Blakely.   

Abstract

Neuropsychiatric disorders have long been linked to both immune system activation and alterations in serotonin (5-HT) signaling. In the CNS, the contributions of 5-HT modulate a broad range of targets, most notably, hypothalamic, limbic and cortical circuits linked to the control of mood and mood disorders. In the periphery, many are aware of the production and actions of 5-HT in the gut but are unaware that the molecule and its receptors are also present in the immune system where evidence suggests they contribute to the both innate and adaptive responses. In addition, there is clear evidence that the immune system communicates to the brain via both humoral and neuronal mechanisms, and that CNS 5-HT neurons are a direct or indirect target for these actions. Following a brief primer on the immune system, we describe our current understanding of the synthesis, release, and actions of 5-HT in modulating immune function, including the expression of 5-HT biosynthetic enzymes, receptors, and transporters that are typically studied with respect to the roles in the CNS. We then orient our presentation to recent findings that pro-inflammatory cytokines can modulate CNS 5-HT signaling, leading to a conceptualization that among the many roles of 5-HT in the body is an integrated physiological and behavioral response to inflammatory events and pathogens. From this perspective, altered 5-HT/immune conversations are likely to contribute to risk for neurobehavioral disorders historically linked to compromised 5-HT function or ameliorated by 5-HT targeted medications, including depression and anxiety disorders, obsessive-compulsive disorder (OCD), and autism. Our review raises the question as to whether genetic variation impacting 5-HT signaling genes may contribute to maladaptive behavior as much through perturbed immune system modulation as through altered brain mechanisms. Conversely, targeting the immune system for therapeutic development may provide an important opportunity to treat mental illness.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23336044      PMCID: PMC3547518          DOI: 10.1021/cn300186b

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  231 in total

1.  Prediction of the depressive effects of interferon alfa therapy by the patient's initial affective state.

Authors:  L Capuron; A Ravaud
Journal:  N Engl J Med       Date:  1999-04-29       Impact factor: 91.245

2.  Serotonin activates dendritic cell function in the context of gut inflammation.

Authors:  Nan Li; Jean-Eric Ghia; Huaqing Wang; Jessica McClemens; Francine Cote; Youko Suehiro; Jacques Mallet; Waliul I Khan
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

3.  A biphasic response of platelets to serotonin.

Authors:  J G White
Journal:  Scand J Haematol       Date:  1970

4.  Increased permeability of primary cultured brain microvessel endothelial cell monolayers following TNF-alpha exposure.

Authors:  K S Mark; D W Miller
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

5.  IFN-beta1b induces kynurenine pathway metabolism in human macrophages: potential implications for multiple sclerosis treatment.

Authors:  G J Guillemin; S J Kerr; L A Pemberton; D G Smith; G A Smythe; P J Armati; B J Brew
Journal:  J Interferon Cytokine Res       Date:  2001-12       Impact factor: 2.607

6.  Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants.

Authors:  S Ramamoorthy; R D Blakely
Journal:  Science       Date:  1999-07-30       Impact factor: 47.728

7.  Enhancement of human natural killer cell cytotoxicity by serotonin: role of non-T/CD16+ NK cells, accessory monocytes, and 5-HT1A receptors.

Authors:  K Hellstrand; S Hermodsson
Journal:  Cell Immunol       Date:  1990-04-15       Impact factor: 4.868

8.  The serotonin transporter (SLC6A4) is present in B-cell clones of diverse malignant origin: probing a potential anti-tumor target for psychotropics.

Authors:  Elizabeth J Meredith; Michelle J Holder; Anita Chamba; Anita Challa; Adrian Drake-Lee; Christopher M Bunce; Mark T Drayson; Geoffrey Pilkington; Randy D Blakely; Martin J S Dyer; Nicholas M Barnes; John Gordon
Journal:  FASEB J       Date:  2005-05-03       Impact factor: 5.191

9.  Cytokines and serotonin transporter in patients with major depression.

Authors:  Chiung-Wen Tsao; Yee-Shin Lin; Chwen-Cheng Chen; Chyi-Huey Bai; Shin-Rung Wu
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2006-03-06       Impact factor: 5.067

10.  Interleukin-1 alpha in blood has direct access to cortical brain cells.

Authors:  W A Banks; A J Kastin; E G Gutierrez
Journal:  Neurosci Lett       Date:  1993-11-26       Impact factor: 3.046

View more
  95 in total

Review 1.  Microbiota and host immune responses: a love-hate relationship.

Authors:  Sarah Tomkovich; Christian Jobin
Journal:  Immunology       Date:  2015-11-02       Impact factor: 7.397

2.  Is there sexual dimorphism of hyperserotonemia in autism spectrum disorder?

Authors:  Lauren C Shuffrey; Stephen J Guter; Shannon Delaney; Suma Jacob; George M Anderson; James S Sutcliffe; Edwin H Cook; Jeremy Veenstra-VanderWeele
Journal:  Autism Res       Date:  2017-04-12       Impact factor: 5.216

Review 3.  Serotonin and Serotonin Transporters in the Adrenal Medulla: A Potential Hub for Modulation of the Sympathetic Stress Response.

Authors:  Rebecca L Brindley; Mary Beth Bauer; Randy D Blakely; Kevin P M Currie
Journal:  ACS Chem Neurosci       Date:  2017-04-13       Impact factor: 4.418

4.  Prolonged stimulation of a brainstem raphe region attenuates experimental autoimmune encephalomyelitis.

Authors:  Pernille M Madsen; Stephanie S Sloley; Alberto A Vitores; Melissa M Carballosa-Gautam; Roberta Brambilla; Ian D Hentall
Journal:  Neuroscience       Date:  2017-01-29       Impact factor: 3.590

Review 5.  Nutritional modulation of the intestinal microbiota; future opportunities for the prevention and treatment of neuroimmune and neuroinflammatory disease.

Authors:  Vincent C Lombardi; Kenny L De Meirleir; Krishnamurthy Subramanian; Sam M Nourani; Ruben K Dagda; Shannon L Delaney; András Palotás
Journal:  J Nutr Biochem       Date:  2018-04-19       Impact factor: 6.048

6.  What's old is new.

Authors:  Anne M Andrews; Lynette C Daws
Journal:  ACS Chem Neurosci       Date:  2013-01-16       Impact factor: 4.418

7.  Modulatory Effects of Antidepressant Classes on the Innate and Adaptive Immune System in Depression.

Authors:  H A Eyre; H Lavretsky; J Kartika; A Qassim; B T Baune
Journal:  Pharmacopsychiatry       Date:  2016-03-07       Impact factor: 5.788

8.  Binding-induced fluorescence of serotonin transporter ligands: A spectroscopic and structural study of 4-(4-(dimethylamino)phenyl)-1-methylpyridinium (APP(+)) and APP(+) analogues.

Authors:  James N Wilson; Lucy Kate Ladefoged; W Michael Babinchak; Birgit Schiøtt
Journal:  ACS Chem Neurosci       Date:  2014-02-05       Impact factor: 4.418

Review 9.  The serotonin system in autism spectrum disorder: From biomarker to animal models.

Authors:  C L Muller; A M J Anacker; J Veenstra-VanderWeele
Journal:  Neuroscience       Date:  2015-11-11       Impact factor: 3.590

Review 10.  Enteric Neuronal Regulation of Intestinal Inflammation.

Authors:  Kara Gross Margolis; Michael D Gershon
Journal:  Trends Neurosci       Date:  2016-07-20       Impact factor: 13.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.